Biologic perspectives to support clinical choices in root canal treatment

Ex Vivo Evaluation of the Accuracy of 3 Electronic Apex Locators in Different Environments: A Micro-Computed Tomography Study

Objective:

The aim of this study was to compare the accuracy of three electronic apex locators (EALs) (Propex Pixi, Mini Root ZX, Raypex 5) in determining working length (WL) under different environments (existence of blood-pulp/sodium hypochlorite in root canal space) using micro-computed tomography (micro-CT) measurements.

Methods:

Twenty-five single-rooted human teeth that were scheduled for extraction were selected for the study. Measurements were performed with the Propex Pixi, Mini Root ZX, Raypex 5 in vivo conditions in the presence of NaOCl irrigant solution or blood-pulp tissue. After that the teeth were extracted and scanned using micro-CT. The measurements of WL obtained with the different EALs in different environments were statistically compared. Significance was set at P<0.05.

Results:

There were no significant differences among the WL measurements performed with EALs or micro CT groups under different clinical enviroments. All EALs tested gave reliable results in respect to apical constriction.

Conclusion:

The accuracy of the tested EALs is not affected by pulp tissues and blood or NaOCl.

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment

Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas regarding incidence, pathogenesis, and prognosis. The purpose of this study was to compare patients with MBC with clinicopathologic and treatment-matched patients with triple-negative breast carcinoma (TNBC) in terms of response to treatment, progression, and survival.Fifty-four patients with MBC and 51 with TNBC, who were treated at Istanbul University, Institute of Oncology, between 1993 and 2014, were included in the study. After correctly matching the patients with 1 of the 2 groups, they were compared to determine differences in response to treatment, disease progression, clinical course, and survival.At a median follow-up of 28 months, 18 patients (17.1%) died and 27 (25.5%) had disease progression. Metaplastic histology was significantly correlated with worse 3-year progression-free survival (PFS) (51 ± 9% vs. 82 ± 6%, P = 0.013) and overall survival (OS) (68 ± 8% vs. 94 ± 4%, P = 0.009) compared with TNBC histology. Patients who received taxane-based chemotherapy (CT) regimens or adjuvant radiotherapy had significantly better PFS (P = 0.002 and P < 0.001) and OS (P < 0.001 and P < 0.001) compared with others. In the multivariate analysis, MBC (hazard ratio [HR]: 0.09, P < 0.001), presence of neoadjuvant chemotherapy (NACT) (HR: 12.8, P = 0.05), and metastasis development at any time during the clinical course (HR: 38.7, P < 0.001) were significant factors that decreased PFS, whereas metastasis development was the only independent prognostic factor of OS (HR: 23.8, P = 0.009).MBC is significantly correlated with worse PFS and OS compared with TNBC. Patients with MBC are resistant to conventional CT agents, and more efficient treatment regimens are required.

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers

Metaplastic sarcomatoid carcinoma (MSC) of the breast is usually triple receptor (ER, PR, and HER2) negative and is not currently recognized as being more aggressive than other triple receptor-negative breast cancers. We reviewed archival tissue sections from surgical resection specimens of 47 patients with MSC of the breast and evaluated the association between various clinicopathologic features and patient survival. We also evaluated the clinical outcome of MSC patients compared to a control group of patients with triple receptor-negative invasive breast carcinoma matched for patient age, clinical stage, tumor grade, treatment with chemotherapy, and treatment with radiation therapy. Factors independently associated with decreased disease-free survival among patients with stage I-III MSC of the breast were patient age > 50 years (P = 0.029) and the presence of nodal macrometastases (P = 0.003). In early-stage (stage I-II) MSC, decreased disease-free survival was observed for patients with a sarcomatoid component comprising ≥ 95% of the tumor (P = 0.032), but tumor size was the only independent adverse prognostic factor in early-stage patients (P = 0.043). Compared to a control group of triple receptor-negative patients, patients with stage I-III MSC had decreased disease-free survival (two-sided log rank, P = 0.018). Five-year disease-free survival was 44 ± 8% versus 74 ± 7% for patients with MSC versus triple receptor-negative breast cancer, respectively. We conclude that MSC of the breast appears more aggressive than other triple receptor-negative breast cancers.

Influence of resin-based adhesive root canal fillings on the resistance to fracture of endodontically treated roots: an in vitro preliminary study

OBJECTIVE

The aim was to investigate the root reinforcing capability of the resin-based RealSeal.

STUDY DESIGN

In two groups (n=36) canals were instrumented with nickel-titanium rotary GTfiles or with hand K-files. Twelve teeth from each group were obturated with lateral compaction using either gutta-percha and AHPlus or RealSeal. The canals of twelve teeth of both groups were instrumented but not filled. Group 3 (n=12) acted as uninstrumented controls. The force required to fracture the roots was measured. ANOVA and Scheffé test were used for statistical analysis.

RESULTS

The intact roots were significantly stronger than both groups with instrumented and unobturated roots (P<.05). Between the roots of both groups obturated with RealSeal and the intact roots there were no significant differences (P>.05). The roots obturated with RealSeal were significantly stronger than those obturated with gutta-percha and AHPlus (P<.05).

CONCLUSIONS

An obturation with RealSeal significantly increases the fracture resistance of instrumented roots.